The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications DOI Creative Commons
Douglas B. Kell, Etheresia Pretorius

Biochemical Journal, Год журнала: 2022, Номер 479(16), С. 1653 - 1708

Опубликована: Авг. 31, 2022

Ischaemia-reperfusion (I-R) injury, initiated via bursts of reactive oxygen species produced during the reoxygenation phase following hypoxia, is well known in a variety acute circumstances. We argue here that I-R injury also underpins elements pathology chronic, inflammatory diseases, including rheumatoid arthritis, ME/CFS and, our chief focus and most proximally, Long COVID. Ischaemia may be fibrin amyloid microclot blockage capillaries, for instance as exercise started; reperfusion necessary corollary when it finishes. rehearse mechanistic evidence these occurrences here, terms their manifestation oxidative stress, hyperinflammation, mast cell activation, production marker metabolites related activities. Such microclot-based phenomena can explain both breathlessness/fatigue post-exertional malaise observed conditions, many other observables. The recognition processes implies, mechanistically, therapeutic benefit potentially to had from antioxidants, anti-inflammatories, iron chelators, suitable, safe fibrinolytics, and/or anti-clotting agents. review considerable existing consistent with this, biochemical mechanisms involved.

Язык: Английский

Periodontal Disease: The Good, The Bad, and The Unknown DOI Creative Commons
Lea M. Sedghi, Margôt Bacino, Yvonne L. Kapila

и другие.

Frontiers in Cellular and Infection Microbiology, Год журнала: 2021, Номер 11

Опубликована: Дек. 7, 2021

Periodontal disease is classically characterized by progressive destruction of the soft and hard tissues periodontal complex, mediated an interplay between dysbiotic microbial communities aberrant immune responses within gingival tissues. Putative pathogens are enriched as resident oral microbiota becomes inflammatory evoke tissue destruction, thus inducing unremitting positive feedback loop proteolysis, inflammation, enrichment for pathogens. Keystone sustained inflammation critical to progression. However, recent studies have revealed importance previously unidentified microbes involved in progression, including various viruses, phages bacterial species. Moreover, newly identified immunological genetic mechanisms, well environmental host factors, diet lifestyle, been discerned years further contributory factors periodontitis. These collectively expanded established narrative In line with this, new ideologies related maintaining health treating existing explored, such application probiotics, limit attenuate The role systemic pathologies, autoimmune disorders diabetes, pathogenesis has noted. Recent additionally reciprocated potentiating states at distal sites, Alzheimer’s disease, bowel diseases, cancer, highlighting cavity health. Here we review long-standing knowledge progression while integrating novel research concepts that broadened our understanding disease. Further, delve into innovative hypotheses may evolve address significant gaps foundational

Язык: Английский

Процитировано

234

Antibiotic perturbations to the gut microbiome DOI
Skye R. S. Fishbein, Bejan Mahmud, Gautam Dantas

и другие.

Nature Reviews Microbiology, Год журнала: 2023, Номер 21(12), С. 772 - 788

Опубликована: Июль 25, 2023

Язык: Английский

Процитировано

174

Targeting the gut microbiota for cancer therapy DOI
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa

и другие.

Nature reviews. Cancer, Год журнала: 2022, Номер 22(12), С. 703 - 722

Опубликована: Окт. 17, 2022

Язык: Английский

Процитировано

149

Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota DOI
Anna E. Lindell, Maria Zimmermann‐Kogadeeva, Kiran Raosaheb Patil

и другие.

Nature Reviews Microbiology, Год журнала: 2022, Номер 20(7), С. 431 - 443

Опубликована: Янв. 31, 2022

Язык: Английский

Процитировано

133

Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis DOI Creative Commons

Weibo Zhong,

Kaihui Wu,

Zining Long

и другие.

Microbiome, Год журнала: 2022, Номер 10(1)

Опубликована: Июнь 16, 2022

Abstract Background The gut microbiota is reportedly involved in the progression and chemoresistance of various human malignancies. However, underlying mechanisms behind how it exerts some effect on prostate cancer, as an extra-intestinal tumor, a contact-independent way remain elusive deserve exploration. Antibiotic exposure, one factors affecting community capable causing dysbiosis, associated with multiple disorders. This study aims to preliminarily clarify link between dysbiosis cancer. Results First, we discovered that perturbing by consuming broad-spectrum antibiotics water promoted growth subcutaneous orthotopic tumors mice. Fecal transplantation could transmit antibiotic exposure tumor growth. Then, 16S rRNA sequencing for mouse feces indicated relative abundance Proteobacteria was significantly higher after exposure. Meanwhile, intratumoral lipopolysaccharide (LPS) profoundly increased under elevation permeability. Both vivo vitro experiments revealed NF-κB-IL6-STAT3 axis activated LPS facilitated cancer proliferation docetaxel chemoresistance. Finally, patients’ fecal samples enriched patients metastatic positively correlated plasma IL6 level, regional lymph node metastasis status, distant status. receiver operating characteristic (ROC) curves showed had better performance than prostate-specific antigen (PSA) level predicting probability (area ROC curve, 0.860; p < 0.001). Conclusion Collectively, this research demonstrated characterized enrichment due resulted permeability LPS, promoting development via Considering findings from patients, might act intestinal biomarker progressive

Язык: Английский

Процитировано

110

Colonic drug delivery: Formulating the next generation of colon-targeted therapeutics DOI Creative Commons
Laura E. McCoubrey,

Alessia Favaron,

Atheer Awad

и другие.

Journal of Controlled Release, Год журнала: 2022, Номер 353, С. 1107 - 1126

Опубликована: Дек. 25, 2022

Colonic drug delivery can facilitate access to unique therapeutic targets and has the potential enhance bioavailability whilst reducing off-target effects. Delivering drugs colon requires considered formulation development, as both oral rectal dosage forms encounter challenges if colon's distinct physiological environment is not appreciated. As opportunities surrounding colonic multiply, success of novel pharmaceuticals lies in their design. This review provides a modern insight into key parameters determining effective design development colon-targeted medicines. Influential features governing release, dissolution, stability, absorption are first discussed, followed by an overview most reliable strategies. Finally, appropriate vitro, vivo, silico preclinical investigations presented, with goal inspiring strategic new therapeutics.

Язык: Английский

Процитировано

110

The spread of antibiotic resistance to humans and potential protection strategies DOI Creative Commons
Dong Ding, Bin Wang, Xiaoan Zhang

и другие.

Ecotoxicology and Environmental Safety, Год журнала: 2023, Номер 254, С. 114734 - 114734

Опубликована: Март 10, 2023

Antibiotic resistance is currently one of the greatest threats to human health. Widespread use and residues antibiotics in humans, animals, environment can exert selective pressure on antibiotic bacteria (ARB) gene (ARG), accelerating flow resistance. As ARG spreads population, burden humans increases, which may have potential health effects people. Therefore, it critical mitigate spread reduce load humans. This review briefly described information global consumption national action plans (NAPs) combat provided a set feasible control strategies for transmission ARB three areas including (a) Reducing colonization capacity exogenous ARB, (b) Enhancing mitigating horizontal transfer (HGT) ARG, (c) Reversing With hope achieving interdisciplinary one-health prevention bacterial

Язык: Английский

Процитировано

107

Deploying Gold Nanomaterials in Combating Multi-Drug-Resistant Bacteria DOI
Xiaohui Zhao, Hao Tang, Xingyu Jiang

и другие.

ACS Nano, Год журнала: 2022, Номер 16(7), С. 10066 - 10087

Опубликована: Июль 1, 2022

Antibiotic resistance has become a serious threat to human health due the overuse of antibiotics. Different antibiotics are being developed treat resistant bacteria, but development cycle is hard keep up with high incidence antibiotic resistance. Recent advances in antimicrobial nanomaterials have made nanotechnology powerful solution this dilemma. Among these nanomaterials, gold excellent antibacterial efficacy and biosafety, making them alternatives This review presents strategies that use combat drug-resistant bacteria. We focus on influence physicochemical factors such as surface chemistry, size, shape their properties describe applications medical devices. Finally, existing challenges future directions discussed.

Язык: Английский

Процитировано

105

The physiology and genetics of bacterial responses to antibiotic combinations DOI
Roderich Roemhild, Tobias Bollenbach, Dan I. Andersson

и другие.

Nature Reviews Microbiology, Год журнала: 2022, Номер 20(8), С. 478 - 490

Опубликована: Март 3, 2022

Язык: Английский

Процитировано

103

Antibiotic combinations reduce Staphylococcus aureus clearance DOI Open Access
Viktória Lázár, Olga Snitser, Daniel Barkan

и другие.

Nature, Год журнала: 2022, Номер 610(7932), С. 540 - 546

Опубликована: Окт. 5, 2022

Язык: Английский

Процитировано

81